Aurora Cannabis Inc. (TSX:ACB)
Canada · Delayed Price · Currency is CAD | Market Cap | 350.25M -10.0% |
| Revenue (ttm) | 314.07M +12.3% |
| Net Income | -120.13M |
| EPS | -2.07 |
| Shares Out | 64.86M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 463,472 |
| Open | 5.36 |
| Previous Close | 5.39 |
| Day's Range | 5.36 - 5.48 |
| 52-Week Range | 3.59 - 9.33 |
| Beta | 1.45 |
| Analysts | Buy |
| Price Target | 5.38 (-0.37%) |
| Earnings Date | Nov 6, 2026 |
About Aurora Cannabis
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products. It also provides harvested cannabis, trim, cannabis oils, capsules, edibles, vaporizers, dried and fresh cannabis, cannabis plants, cannabis seeds, edible cannabis, cannabis extracts, flowers, vapes / inhalable extracts, edibles / pastilles, concentrates, and cannabis topicals; and patient ... [Read more]
Full Company ProfileFinancial Performance
Financial StatementsAnalyst Summary
According to 5 analysts, the average rating for ACB stock is "Buy." The 12-month stock price target is $5.38, which is a decrease of -0.37% from the latest price.
News
Aurora Cannabis reaffirms Q2 guidance guidance for sequential growth in revenue
Aurora Cannabis (ACB) provided a business update, highlighting the expected additional benefits of the Safari Flower Company acquisition, continued strong performance in key high margin international ...
Aurora Cannabis Provides Business Update; Accretive Acquisition of Safari Flower Company and Leading European Performance Expected to Fuel International Growth in the Fiscal Second Quarter 2027 and Beyond
NASDAQ| TSX: ACB Re-affirms FY27 Q2 guidance for sequential growth in quarterly net revenue and adjusted EBITDA 1 Following the receipt of EU-GMP certification in July, Safari Flower Company is expect...
Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid
Cross-border consolidation in the cannabis industry has moved from executive speculation into aggressive dealmaking. As regulatory hurdles begin to clear across North America and Europe, operators are...
Curaleaf Urges Aurora Shareholders To Back Bid, Seeks Halt To ATM Program
(RTTNews) - Curaleaf Holdings Inc. (CURLF) urged Aurora Cannabis Inc. (ACB.TO) shareholders to support its takeover offer. Further, Curaleaf has asked the Alberta Securities Commission or ASC to halt ...
Curaleaf urges Aurora Cannabis shareholders to accept its offer
Curaleaf Holdings (CURLF) urged shareholders of Aurora Cannabis (ACB) to accept its offer, realize a 45% premium, and participate in the future upside of the world’s leading cannabis company. In…
Aurora refutes Curaleaf’s ‘latest attempt to distract shareholders from facts’
Aurora Cannabis (ACB) responded to the application by Curaleaf Holdings (CURLF) to halt Aurora’s at-the-market program, stating: “Aurora believes Curaleaf’s filing is simply the latest attempt to dist...
Aurora Cannabis Refutes Curaleaf's Latest Attempt To Distract Shareholders From The Facts
NASDAQ | TSX: ACB Curaleaf's announcement is a desperate effort to shift attention away from the fundamental issue facing shareholders: its inadequate hostile bid undervalues Aurora. Curaleaf's attemp...
Curaleaf applies to ASC to halt Aurora’s ATM program during pending offer
Curaleaf Holdings (CURLF) announced that it has filed an application with the Alberta Securities Commission to remedy abuse by Aurora (ACB) of its at-the-market share issuance program by ceasing the…
Aurora Appoints Seasoned Biopharmaceutical Executive to Lead Commercial Acceleration of Global Medical Cannabis Business
EDMONTON, AB, Sept. 9, 2026 /PRNewswire/ -- Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces Faris El Refaie, a biopharmaceutical le...
Curaleaf issues fact sheet to address ‘misleading’ statements from Aurora
Curaleaf Holdings (CURLF) released a fact sheet addressing a number of “inaccurate and misleading statements” made by Aurora Cannabis (ACB) in connection with Curaleaf’s proposal to acquire Aurora. “W...
Aurora Cannabis Stock (ACB) Trending as Company Urges Shareholders to Reject Hostile Takeover Bid
Aurora Cannabis ($ACB) is urging its shareholders to reject a hostile takeover bid by rival Curaleaf Holdings ($TSE:CURA).
'We think they should reject this offer': Aurora Cannabis CEO's on Curaleaf bid
Miguel Martin, CEO of Aurora Cannabis, joins BNN Bloomberg to discuss the Curalead bid on the company.
Curaleaf says offer ‘best path to value creation’ for Aurora shareholders
Curaleaf Holdings (CURLF) responded to “misleading statements” contained in Aurora Cannabis’ (ACB) Directors’ Circular and reiterated its belief that the Curaleaf offer “represents the most compelling...
Aurora Cannabis Calls Curaleaf Offer Inadequate, Urges Rejection
Aurora Cannabis is urging its shareholders to reject an unsolicited $272 million hostile takeover bid from Curaleaf Holdings.
Aurora Cannabis urges shareholders reject Curaleaf take-over bid
Aurora Cannabis (ACB) urged shareholders to reject the unsolicited take-over bid from Curaleaf (CURLF), warning that the Hostile Bid would put Aurora shareholders’ value and future upside at risk. Fol...
Aurora Cannabis Urges Shareholders to REJECT Curaleaf's Hostile Bid, Warning that it is Inadequate, Undervalues Aurora and Puts Shareholder Value and Future Upside at Risk
NASDAQ | TSX: ACB Curaleaf's hostile and opportunistic bid significantly undervalues Aurora, and aims to capture Aurora's assets at a discount Aurora is debt free and holds $149 million in cash 1 , Cu...
Is Aurora Cannabis Stock a Buy as Curaleaf Pushes a Hostile Takeover Bid?
Curaleaf is offering Aurora shareholders $4 per share. Aurora believes Curaleaf's hostile bid undervalues the company.
The Best Way Marijuana Stock Investing Can Work For You
As the cannabis industry continues to grow worldwide, there is a strong focus on the future. Many new changes are occurring throughout the sector—many of these impact businesses, investors, and potent...
Curaleaf says Aurora’s characterization of engagement ‘misleading’
Curaleaf Holdings (CURLF) responded to Aurora Cannabis’ (ACB) latest public statements regarding Curaleaf’s offer for Aurora, stating in part: “Aurora’s hollow protests and completely misleading stati...
Curaleaf Responds to Aurora Cannabis' Latest Attempt to Deflect From Shareholder Value Creation
Aurora's selective statistics and misleading characterization of engagement do not obscure years of underperformance and lost shareholder value Curaleaf reiterates its willingness to meet anytime to d...
Aurora Cannabis says Curaleaf takeover bid ‘should be viewed skeptically’
Aurora Cannabis (ACB) cautioned shareholders that Curaleaf Holdings (CURLF) announcement of an unsolicited take-over bid appears to contain inaccurate statements about Aurora’s business and should be ...
AURORA CANNABIS CORRECTS INACCURATE STATEMENTS MADE IN SUPPORT OF CURALEAF HOLDINGS' HOSTILE BID
Curaleaf's self-serving portrayal of our business is an attempt to acquire Aurora's world class EU-GMP manufacturing facilities and global medical cannabis footprint at the lowest price possible Auror...
The Cannabis M&A Wave Is Here. Curaleaf Proved It.
Green Thumb Industries is one of the few U.S. cannabis companies that has been consistently profitable. The company grew revenue and earnings in the second quarter.
Curaleaf's Hostile Takeover Bid for Aurora Is Just the Tip of the Iceberg for Cannabis Consolidation. These 2 Stocks Could Be the Biggest Winners.
Curaleaf has made an unsolicited bid for Aurora Cannabis. Aurora recently completed its acquisition of Safari Flower.
Is Curaleaf Stock a Buy With Its Attempted Hostile Takeover of Aurora Cannabis Under Way?
Curaleaf reiterated the offer it made public last week. Aurora stock continues to trade at a discount to the base offer price.